Close

Integra Lifesciences (IART) Misses Q1 EPS by 30c; Trims Outlook

May 2, 2013 9:32 AM EDT Send to a Friend
Integra Lifesciences Holdings (NASDAQ: IART) reported Q1 EPS of $0.39, $0.30 worse than the analyst estimate ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login